This is a B.C. news story, published by Global News, that relates primarily to Andie Warnes news.
For more B.C. news, you can click here:
more B.C. newsFor more Andie Warnes news, you can click here:
more Andie Warnes newsFor more disease research news, you can click here:
more disease research newsFor more news from Global News, you can click here:
more news from Global NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
cell lymphoma. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest new cancerous tumour news, aggressive chemotherapy news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
cancerGlobal News
•
63% Informative
Andie Warnes , 40 , was diagnosed with large B-cell lymphoma last year and underwent aggressive chemo.
She is the first person in B.C. to get CAR-T cell therapy approved as a second line treatment.
The treatment involves taking the patient’s immune cells and genetically altering them in a lab to fight cancer.
VR Score
48
Informative language
37
Neutral language
57
Article tone
informal
Language
English
Language complexity
36
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links